NCT05569239 Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05565586 Impact of High Dietary Fiber on Microbiome and Vaccine Responses Status ACTIVE_NOT_RECRUITING Phase NA
NCT05558462 Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers Status COMPLETED Phase NA
NCT05544916 A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections Status COMPLETED Phase PHASE3
NCT05542004 Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Status COMPLETED Phase NA
NCT05523089 The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults Status COMPLETED Phase PHASE2
NCT05519839 A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine Status COMPLETED Phase PHASE2
NCT05517174 A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults Status COMPLETED Phase PHASE4
NCT05509283 Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications Status COMPLETED Phase NA
NCT05494047 Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile Status UNKNOWN Phase PHASE3
NCT05493787 Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot Status COMPLETED Phase NA
NCT05474755 To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection Status COMPLETED Phase PHASE3
NCT05436184 Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05406180 Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above Status COMPLETED Phase N/A
NCT05389137 To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years Status UNKNOWN Phase PHASE4